Isabel Beerman

Isabel Beerman

Auto-generated profile, based on publicly available information

Isabel Beerman

Epigenetics and Stem Cell Unit, Translational Gerontology Branch, National Institute on Aging, NIH, Baltimore, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
WPWendy W. Pang
Wendy W. Pang
EPElizabeth A. Price
Elizabeth A. Price
DSDebashis Sahoo
Debashis Sahoo
IBIsabel Beerman
Isabel Beerman
WMWilliam J. Maloney
William J. Maloney
IWIrving L. Weissman
Irving L. Weissman
In the human hematopoietic system, aging is associated with decreased bone marrow cellularity, decreased adaptive immune system function, and increased incidence of anemia and other hematological disorders and malignancies. Recent studies in mice suggest that changes within the hematopoietic stem cell (HSC) population during aging contribute significantly to the manifestation of these age-associated hematopoietic pathologies. Though the mouse HSC population has been shown to change both quantitatively and functionally with age, changes in the human HSC and progenitor cell populations during aging have been incompletely characterized. To elucidate the properties of an aged human hematopoietic system that may predispose to age-associated hematopoietic dysfunction, we evaluated immunophenotypic HSC and other hematopoietic progenitor populations from healthy, hematologically normal young and elderly human bone marrow samples. We found that aged immunophenotypic human HSC increase in frequency, are less quiescent, and exhibit myeloid-biased differentiation potential compared with young HSC. Gene expression profiling revealed that aged immunophenotypic human HSC transcriptionally up-regulate genes associated with cell cycle, myeloid lineage specification, and myeloid malignancies. These age-associated alterations in the frequency, developmental potential, and gene expression profile of human HSC are similar to those changes observed in mouse HSC, suggesting that hematopoietic aging is an evolutionarily conserved process.

23 March 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
IBIsabel Beerman
Isabel Beerman
DBDeepta Bhattacharya
Deepta Bhattacharya
SZSasan Zandi
Sasan Zandi
MSMikael SIgvardsson
Mikael SIgvardsson
IWIrving L. Weissman
Irving L. Weissman
DRDerrick J. Rossi
Derrick J. Rossi
Aging of the hematopoietic stem cell compartment is believed to contribute to the onset of a variety of age-dependent blood cell pathophysiologies. Mechanistic drivers of hematopoietic stem cell (HSC) aging include DNA damage accumulation and induction of tumor suppressor pathways that combine to reduce the regenerative capacity of aged HSCs. Such mechanisms do not however account for the change in lymphoid and myeloid lineage potential characteristic of HSC aging, which is believed to be central to the decline of immune competence and predisposition to myelogenous diseases in the elderly. Here we have prospectively isolated functionally distinct HSC clonal subtypes, based on cell surface phenotype, bearing intrinsically different capacities to differentiate toward lymphoid and myeloid effector cells mediated by quantitative differences in lineage priming. Finally, we present data supporting a model in which clonal expansion of a class of intrinsically myeloid-biased HSCs with robust self-renewal potential is a central component of hematopoietic aging.

13 March 2011 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AGAli G Gharavi
Ali G Gharavi
KKKrzysztof Kiryluk
Krzysztof Kiryluk
MCMurim Choi
Murim Choi
YIFU LIYIFU LI
YIFU LI
PHPing Hou
Ping Hou
RLRichard P Lifton
Richard P Lifton

1 April 2013 in Cell Stem Cell
Verified
Journal Article
Closed access
IBIsabel Beerman
Isabel Beerman
CBChristoph Bock
Christoph Bock
BGBrian S. Garrison
Brian S. Garrison
ZSZachary D. Smith
Zachary D. Smith
HGHongcang Gu
Hongcang Gu
DRDerrick J. Rossi
Derrick J. Rossi

1 July 2014 in Cell Stem Cell
Verified
Journal Article
Closed access
IBIsabel Beerman
Isabel Beerman
JSJun Seita
Jun Seita
MIMatthew A. Inlay
Matthew A. Inlay
IWIrving L. Weissman
Irving L. Weissman
DRDerrick J. Rossi
Derrick J. Rossi

1 August 2012 in Molecular Cell
Verified
Journal Article
Closed access
CBChristoph Bock
Christoph Bock
IBIsabel Beerman
Isabel Beerman
WLWen-Hui Lien
Wen-Hui Lien
ZSZachary D. Smith
Zachary D. Smith
HGHongcang Gu
Hongcang Gu
AMAlexander Meissner
Alexander Meissner